Skip to main content
Log in

Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Two patients experienced hepatotoxicity associated with erythromycin estolate (ilosone®) usage, followed 13 and 15 years later by an hepatotoxic reaction with administration of erythromycin ethylsuccinate (E.E.S.®). These cases provide further evidence for erythromycin ethylsuccinate-associated hepatotoxicity and demonstrate erythromycin crosssensitivity after previous erythromycin estolate liver injury. Hepatotoxicity to both estolate and ethylsuccinate preparations of erythromycin stimulates speculation regarding the potentially hepatotoxic moiety of the erythromycin molecule. Furthermore, these cases suggest that all erythromycin preparations should be avoided or used only with careful monitoring in patients with previous erythromycin-associated liver injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cacace LG, Schweigert BF, Gildon AM: Erythromycin estolate induced hepatotoxicity: Report of a case and review of the literature. Drug Intell Clin Pharm 11:22–25, 1977

    Google Scholar 

  2. Zafrani ES, Ishak KG, Rudzki C: Cholestatic and hepatocellular injury associated with erythromycin esters. Report of nine cases. Dig Dis Sci 24:385–396, 1979

    PubMed  Google Scholar 

  3. Zimmerman HJ: Hepatotoxicity. New York, Appleton-Century-Crofts, 1978

    Google Scholar 

  4. Anonymous. Choice and uses of the erythromycin drugs. Med Lett Drugs Ther 12:35–36, 1970

  5. Ticktin HE, Robinson MM: Effects of some antimicrobial agents on the liver. Ann NY Acad Sci 104:1080–1092, 1963

    Google Scholar 

  6. Tolman KG, Sannella JJ, Freston JW: Chemical structure of erythromycin and hepatotoxicity. Ann Intern Med 81:58–60, 1974

    PubMed  Google Scholar 

  7. Pessayre D, Marie C, Benhamou JP: Hepatite due au priopionate d'erythromycine. Arch Fr Mal App Dig 65:405–408, 1976

    PubMed  Google Scholar 

  8. Klatskin G: Toxic and drug-induced hepatitis.In Diseases of the Liver, 4th ed. L Schiff (ed). Philadelphia, JB Lippincott, 1975, pp 604–710

    Google Scholar 

  9. Viteri AL, Greene JF Jr, Dyck WP: Erythromycin ethylsuccinate-induced cholestasis. Gastroenterology 76:1007–1008, 1979

    PubMed  Google Scholar 

  10. Sullivan D, Csuka ME, Blanchard B: Erythromycin ethylsuccinate hepatotoxicity. J Am Med Assoc 243:1074, 1980

    Google Scholar 

  11. Gilbert FI Jr: Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. J Am Med Assoc 182: 1048–1050, 1962

    Google Scholar 

  12. Farmer CD, Hoffman HN II, Shorter RG, Thurber DL, Bartholomew LG: Intrahepatic cholestasis associated with the ingestion of erythromycin estolate (Ilosone). Gastroenterology. 45:157–160, 1963

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keeffe, E.B., Reis, T.C. & Berland, J.E. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate. Digest Dis Sci 27, 701–704 (1982). https://doi.org/10.1007/BF01393764

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01393764

Keywords

Navigation